Evestia Clinical – the new brand identity for EMAS Pharma – launches today as a market leading pharmaceutical research specialist focused on Clinical Trials in Oncology and Rare Diseases
Evestia Clinical has today been announced as the new identity of EMAS Pharma, as it sets its sights on rapid growth as a provider of clinical research in oncology and rare diseases globally.
Read more
